Multiple myeloma in Brazil
An assessment of Global Burden Disease study 2019
Bibliographic Data
| ID | 5333998 |
|---|---|
| Authors | Max Moura De Oliveira (0000-0002-0804-5145, Universidade Federal de Goiás), Guilherme Augusto Veloso (0000-0002-5348-3793, Universidade Federal Fluminense), Deborah Carvalho Malta (0000-0002-8214-5734, Universidade Federal de Minas Gerais), Maria Paula Curado (0000-0001-8172-2483, A.C.Camargo Cancer Center Epidemiologia, Brasil), Cristiane A Menezes De Pádua (0000-0001-7083-3188, Universidade Federal de Minas Gerais) |
| Year | 2024 |
| Volume | 48 |
| Issue | 142 |
| Publication date | 2024-01-01 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Saúde em Debate (JOURNAL) |
| Journal identifiers | ISSN: 0103-1104 • E-ISSN: 2358-2898 |
| Publisher | FapUNIFESP (SciELO) (PUBLISHER) |
| DOI | 10.1590/2358-289820241428855i |
| OpenAlex | W4403606800 |
| SCIELO_PID | S0103-11042024000300212 |
| Language | EN |
| References cited | 20 |
Multiple myeloma is the second most common hematological cancer; it accounts for approximately 10% of all hematologic malignancies and 1%-2% of all cancer diagnoses. From 1990 to 2019, an ecological study was conducted to describe and evaluate trends in Brazil's morbidity, mortality, and disease. The Global Burden of Disease data described age-standardized (+40 years) incidence, prevalence, mortality, disability-adjusted life years, and its components in Brazil and across its 27 federative units according to sex and Socio-demographic Index quintiles. Trends were estimated using linear regression and expressed as Average Annual Percentage Changes (AAPC) and 95% Confidence Intervals (CI). Ascending trends of the measures were found for both sexes in Brazil and its federative units. Mortality increased to a lesser extent than incidence (AAPC=1.3%; 95%CI=1.2-1.3 vs. AAPC=1.5%; 95%CI= 1.5-1.5 for men; AAPC=0.9%; 95%CI=0.9-0.9 vs. AAPC=1.1%; 95%CI=1.1-1.2 for women), resulting in higher rising trends in prevalence for both sexes. All the measures were significantly higher in high- and high-middle socio-demographic quintiles; however, higher ascending trends were found in lower socio-demographic quintiles. Aging, level of development, diagnosis, and treatment appear to explain Brazil's ascending multiple myeloma rates and their differences among the federative units
Burden of disease · Disease · Disease burden · Multiple myeloma · Internal Medicine · Medicine · Multiple Myeloma Research and Treatments · Public Health in Brazil
Permutation tests for joinpoint regression with applications to cancer rates
Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019
Secular Trends in the Burden of Multiple Myeloma From 1990 to 2019 and Its Projection Until 2044 in China
The tale of lenalidomide clinical superiority over thalidomide and regulatory and cost-effectiveness issues
| Citation velocity | historical |
|---|---|
| Highly cited | No |